Therapeutic approaches in proteinopathies

Area of Science:

• Biochemistry
• Pathology
• Pharmacology

Background:

• Amyloid disorders, also known as proteinopathy or amyloidosis, are characterized by the accumulation of abnormal protein aggregates forming cross-β-sheet amyloid fibrils in various organs.
• These fibrils are often composed of misfolded or improperly folded proteins.
• Current treatments for amyloid diseases primarily focus on symptom management rather than addressing the underlying disease process.

Purpose of the Study:

• To review current understanding of amyloid disease biology.
• To highlight recent advances in therapeutic strategies targeting amyloid fibril formation and accumulation.
• To discuss the potential of novel treatments for amyloidosis.

Main Methods:

• Literature review of recent advances in amyloidosis research.
• Analysis of emerging therapeutic modalities including small compounds, monoclonal antibodies, and gene therapy.
• Synthesis of current knowledge on amyloid disease pathogenesis and treatment.

Main Results:

• Significant progress has been made in understanding the biological mechanisms underlying amyloid diseases.
• Innovative therapies targeting the initiation and progression of amyloid fibril formation are under development.
• These novel approaches include small molecules, antibody-based therapies, and gene therapy strategies.

Conclusions:

• While most current amyloid disease therapies are symptomatic, ongoing research is identifying new therapeutic targets.
• Advances in understanding amyloidosis biology are paving the way for more effective treatments.
• Future therapeutic strategies aim to prevent or reverse the accumulation of amyloid fibrils, offering potential cures.